Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders

@inproceedings{Federico1997ProtonMR,
  title={Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders},
  author={Francesco Federico and Isabella Laura Simone and Vincenzo Lucivero and Giovanni Iliceto and Michele de Mari and P. Giannini and Domenico M. Mezzapesa and A Tarantino and Paolo Lamberti},
  year={1997}
}
Proton magnetic resonance spectroscopy (1H-MRS), localized to the lentiform nucleus, was carried out in 12 patients with idiopathic Parkinson's disease (IPD), seven patients with multiple-system atrophy (MSA), seven patients with progressive supranuclear palsy (PSP), and 10 healthy age matched controls. The study assessed the level of N-acetylaspartate (NAA), creatine–phosphocreatine (Cr), and choline (Cho) in the putamen and globus pallidus of these patients. NAA/Cho and NAA/Cr ratios were… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 27 CITATIONS

Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes

  • The Italian Journal of Neurological Sciences
  • 1999
VIEW 6 EXCERPTS
CITES RESULTS & BACKGROUND